Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
First Edition BOGP (0)
Australie (1)
Advocacy (policy advocacy, lobbying)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Representativeness of stakeholders
Clinical study phase II